OR WAIT null SECS
© 2021 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2021 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
December 07, 2021
December 06, 2021
December 03, 2021
Read the most up-to-date information about the latest developments in psoriatic arthritis
The impact of psoriatic arthritis on patients’ quality of life and importance of an early, accurate diagnosis.
Test your knowledge of RA with this quiz
Learn more about the latest developments in rheumatoid arthritis
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending December 3, 2021.
December 02, 2021
“Managing pain is an important treatment goal in patients with ankylosing spondylitis, however, pain is often underestimated by clinical disease activity scoring tools, and 20% to 30% of patients report pain despite treatment with TNFis,” investigators stated.
December 01, 2021
Stuart Kassan, MD, discusses Rheumatology Research Foundation's recent patient webinar, "Just Diagnosed: Now What?”
Philip Mease, MD, explains the recent Phase 3 data from the DISCOVER-1 and DISCOVER-2 clinical trials which demonstrated guselkumab inhibited radiographic progression, and improved symptoms and pain in patients with active psoriatic arthritis (PsA).
November 30, 2021
Louis Bessette, MD, MSc, explains the impact of early pain improvement on patient-reported outcomes in patients with psoriatic arthritis.
Benjamin Terrier, MD, PhD, discusses his study and ACR presentation, “Rituximab versus Conventional Therapeutic Strategy for Remission Induction in Eosinophilic Granulomatosis with Polyangiitis: A Double-blind, Randomized, Controlled Trial.”
November 29, 2021
Paul R. Fortin, MD, MPH, FRCPC, discusses the impact of the COVID-19 vaccine in immunosuppressed adults and those with autoimmune diseases.
November 26, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending November 26, 2021.
November 25, 2021
Ana-Maria Orbai, MD, FACR, MHS, explains how guselkumab improved PROMIS-29 scores in patients with psoriatic arthritis.
November 24, 2021
Soumya Chakravarty, MD, PhD, discusses the unmet patient needs in immune-mediated diseases and Janssen’s role in scientific innovation that allows patients to live their lives unburdened by disease.